Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy
出版年份 2022 全文链接
标题
Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy
作者
关键词
-
出版物
ACS Nano
Volume 16, Issue 10, Pages 15977-15993
出版商
American Chemical Society (ACS)
发表日期
2022-10-04
DOI
10.1021/acsnano.2c03509
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma
- (2021) Y. Zhang et al. Clinical & Translational Oncology
- Intratumoral heterogeneity in cancer progression and response to immunotherapy
- (2021) Ilio Vitale et al. NATURE MEDICINE
- Nanocatalytic Innate Immunity Activation by Mitochondrial DNA Oxidative Damage for Tumor‐Specific Therapy
- (2021) Han Jiang et al. ADVANCED MATERIALS
- Spatial Order of Functional Modules Enabling Diverse Intracellular Performance of Fluorescent Probes
- (2021) Chong Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer
- (2021) Jiaqi Shi et al. CELLULAR IMMUNOLOGY
- Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist
- (2021) Shanshan Gou et al. NANO LETTERS
- Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy
- (2021) Xiaoqi Sun et al. Nature Nanotechnology
- Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy via Enhancing Innate Immunity
- (2020) Lin Hou et al. ACS Nano
- Multifunctional STING‐Activating Mn 3 O 4 @Au‐dsDNA/DOX Nanoparticle for Antitumor Immunotherapy
- (2020) Min Zhou et al. Advanced Healthcare Materials
- A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer: Protocol-Specified Final Analysis of KEYNOTE-407
- (2020) Luis Paz-Ares et al. Journal of Thoracic Oncology
- Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
- (2020) Leila Motedayen Aval et al. Journal of Clinical Medicine
- In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy
- (2020) Jiayu Zhao et al. BIOMATERIALS
- Light-driven formation of manganese oxide by today’s photosystem II supports evolutionarily ancient manganese-oxidizing photosynthesis
- (2020) Petko Chernev et al. Nature Communications
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- A Cobalt‐Based Amorphous Bifunctional Electrocatalysts for Water‐Splitting Evolved from a Single‐Source Lazulite Cobalt Phosphate
- (2019) Prashanth W. Menezes et al. ADVANCED FUNCTIONAL MATERIALS
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
- (2019) Aparna R. Parikh et al. NATURE MEDICINE
- Intra/Extracellular Lactic Acid Exhaustion for Synergistic Metabolic Therapy and Immunotherapy of Tumors
- (2019) Fan Gao et al. ADVANCED MATERIALS
- Nd3+-Sensitized Upconversion Metal-Organic Frameworks for Mitochondria-Targeted Amplified Photodynamic Therapy
- (2019) Chang Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
- (2019) Stephen J. Bagley et al. PHARMACOLOGY & THERAPEUTICS
- Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses
- (2018) Chenguang Wang et al. IMMUNITY
- Targeting Photoinduced DNA Destruction by Ru(II) Tetraazaphenanthrene in Live Cells by Signal Peptide
- (2018) Christopher S. Burke et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- DNA-induced liquid phase condensation of cGAS activates innate immune signaling
- (2018) Mingjian Du et al. SCIENCE
- Targeting STING with covalent small-molecule inhibitors
- (2018) Simone M. Haag et al. NATURE
- Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
- (2018) Huayang Liu et al. NATURE MEDICINE
- Cytoplasmic chromatin triggers inflammation in senescence and cancer
- (2017) Zhixun Dou et al. NATURE
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- ACPI Conjugated Gold Nanorods as Nanoplatform for Dual Image Guided Activatable Photodynamic and Photothermal Combined Therapy In Vivo
- (2017) Wen-Xiu Qiu et al. Small
- Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
- (2017) Guangbao Yang et al. Nature Communications
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
- (2016) Yoshihiro Komohara et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
- (2015) J. R. Baird et al. CANCER RESEARCH
- Evolution of the immune system in humans from infancy to old age
- (2015) A. Katharina Simon et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More